Criminal Justice Drug Abuse Treatment Studies 2: Medication-Assisted Therapy, 2010-2013 [United States] (ICPSR 34988)

Published: Feb 2, 2016

Principal Investigator(s):
Peter Friedmann, Rhode Island Hospital, and Brown University; Michael Prendergast, University of California-Los Angeles; Michael Shafer, Arizona State University; Linda Frisman, University of Connecticut; Christy Visher, University of Delaware; Carl Leukefeld, University of Kentucky; Stanley Sacks, National Development and Research Institutes, Inc.; Lyn Stein, University of Rhode Island; Kevin Knight, Texas Christian University; Steven Belenko, Temple University; Lori Ducharme, United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse

Series:

https://doi.org/10.3886/ICPSR34988.v1

Version V1

CJ-DATS 2: MAT

The Criminal Justice Drug Abuse Treatment Studies 2 (CJ-DATS 2) was launched in 2008 with a focus on conducting implementation research in criminal justice settings. NIDA's ultimate goal for CJ-DATS 2 was to identify implementation strategies that maximize the likelihood of sustained delivery of evidence-based practices to improve offender drug abuse and HIV outcomes, and to decrease their risk of incarceration.

The Medication-Assisted Therapy (MAT) study focuses on implementing linkages to medication assisted treatment in correctional settings. During the study period community corrections staff engaged in training about addiction pharmacotherapies, while leadership in the corrections and treatment facilities engage in a joint strategic planning process to identify and resolve barriers to efficient flow of clients across the two systems.

This study includes 28 datasets and over 1,400 variables. The first five datasets for this study contain data on the baseline characteristics of the treatment and corrections sites that participated in the study as well as the characteristics of the staff working at those facilities. Opinions about Medication Assisted Treatment surveys were administered to personnel at the participating corrections and treatment sites (D6). Data on Inter-organization Relations between Probation and Parole staff with Treatment Providers were also collected (DS7-DS18).

Information was extracted from the charts of clients about their alcohol and opioid dependence as well as the referrals and treatment the clients received (DS19). Probation and parole officers and treatment providers were surveyed about monthly counts of referrals (DS20-DS21).

During the study 10 staff members from the community corrections agency and local treatment providers where MAT services were available were nominated to participate in a Pharmacotherapy Exchange Council (PEC). PEC members were involved with strategic planning for implementing changes to improve the usage of Medication-Assisted Therapy. PEC members were surveyed several times throughout the study.

PEC members completed surveys on how well the sites were adhering to the Organizational Linkages Intervention (OLI) process (DS22). Community corrections staff, PEC members and Connections Coordinators in the experimental group were surveyed about their perceptions of organizational benefits and costs associated with the MATICCE intervention (DS23). The PEC rated the Connections Coordinators (DS24)and the Connections Coordinators rate the PEC (DS25). PEC researchers completed surveys on how much of the OLI was completed (DS26) as well as what the sustainability of the changes made through the MATTICE project (DS27). The final dataset provides a key for who took the KPI (Key Performance Indicators) training and who was a PEC member (DS28).

Friedmann, Peter, Prendergast, Michael, Ducharme, Lori, Shafer, Michael, Frisman, Linda, Visher, Christy, … Belenko, Steven. Criminal Justice Drug Abuse Treatment Studies 2: Medication-Assisted Therapy, 2010-2013 [United States]. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2016-02-02. https://doi.org/10.3886/ICPSR34988.v1

Export Citation:

  • RIS (generic format for RefWorks, EndNote, etc.)
  • EndNote

United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse (U01DA025307, U01DA016194, U01DA016230, U01DA025233, U01DA016205, U01DA016200, U01DA016191, U01DA016190, U01DA025284, U01DA016211)

United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration

United States Department of Justice. Office of Justice Programs. Bureau of Justice Assistance

Users are reminded that these data are to be used solely for statistical analysis and reporting of aggregated information and not for the investigation of specific individuals.

2010 -- 2013

ICPSR performed recodes on select variables to protect respondent confidentiality. See the "Processing/Confidentiality Notes" in each codebook for further details.

ICPSR edited variable labels to provide users with more information and increase comparability across variables sets and datasets.

The objective of this study was to leverage treatment services that already exist in the community. This means that the implementation strategy was not designed to promote the delivery of clinical services nor medication prescribing within or by probation and parole offices, but rather was targeted at facilitating linkages between organizations that, despite sharing the same clients, lack incentive to coordinate services, or otherwise do not view themselves as sharing a common mission.

Nine research centers partnered with stakeholder organizations to improve utilization of medical-assisted therapy. Each research center recruited two community corrections agencies that did not have overlapping administrative structures. The pairs of sites were used in a clustered randomized design experiment. One research center recruited a second pair of sites brining the total number of sites to 20.

The sites' staff received a 3-hour medical assisted therapy. Next the experimental group of sites were assigned to received an Organization Linkage Intervention and were asked to nominate members of a "Pharmacotherapy Exchange Council" (PEC). The PEC went through a manualized strategic planning process with the end goal of facilitating inter-organization linkages and increase awareness about the effectiveness of Medication-assisted therapy.

All applicable personnel at each study site were invited to participate.

Longitudinal: Panel

Probation, parole, and treatment personnel in the United States 2010-2013.

Individual

administrative records data

survey data

Part 1: CD 91.3 percent / CO 91.2 percent / TD 95.8 percent / TS 84.5 percent

Part 2: 80.0 percent

Part 3: 85.7 percent

Part 4: Same as part 1

Part 5: N/A

Part 6: Baseline 85.2 percent / 3 Month 80.5 percent / 12 Month 74.5 percent

Part 7: 86.1 percent

Part 8: 72.9 percent

Part 9: 80.4 percent

Part 10: 82.2 percent

Part 11: 90.8 percent

Part 12: 93.3 percent

Part 13: 70.6 percent

Part 14: 95.0 percent

Part 15: 96.3 percent

Part 16: 90.6 percent

Part 17: 78.3 percent

Part 18: 92.3 percent

Part 19: N/A

Part 20: 98.2 percent

Part 21: 93.6 percent

Part 22: 100 percent

Part 23: 98.2 percent

Part 24: 93.3 percent

Part 25: 99.3 percent

Part 26: 100 percent

Part 27: 100 percent

Part 28: N/A

Please review the scoring guides in the provided user guide.

2016-02-02

2016-02-02

2016-02-02 ICPSR data undergo a confidentiality review and are altered when necessary to limit the risk of disclosure. ICPSR also routinely creates ready-to-go data files along with setups in the major statistical software formats as well as standard codebooks to accompany the data. In addition to these procedures, ICPSR performed the following processing steps for this data collection:

  • Created variable labels and/or value labels.
  • Created online analysis version with question text.
  • Checked for undocumented or out-of-range codes.

There are no weights associated with this study.

Notes

  • The public-use data files in this collection are available for access by the general public. Access does not require affiliation with an ICPSR member institution.

NAHDAP logo

This study is maintained and distributed by the National Addiction & HIV Data Archive Program (NAHDAP). NAHDAP is supported by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH).